Scientific Programme

The Future Of HBV Functional Cure

Back

Free Paper Session
Antiviral effects of oral farnesoid X receptor agonist vonafexor combined with pegylated interferon alpha2a in untreated patients with chronic hepatitis B – Dr. Bettina Hansen

2 June 2022
2.00pm – 2.30pm